Naomi M. Hamburg, MD, MS

Joseph A. Vita, MD Professor, Boston University Chobanian & Avedisian School of Medicine

Biography

Dr. Hamburg is the inaugural Joseph A. Vita Professor of Medicine, Chief of the Vascular Biology Section, interim Director of the Whitaker Cardiovascular Institute at Boston University School of Medicine and an Attending in the Cardiovascular Medicine Section at Boston Medical Center. Dr. Hamburg is a recognized expert in the field of Vascular Medicine and the clinical translation of Vascular Biology. Her research work seeks to understand approaches to restore vascular health in patients with cardiometabolic disorders, peripheral artery disease, and to evaluate the impact of novel tobacco products and long COVID. Her work has been continuously funded by the National Institutes of Health and foundations since 2006. Dr. Hamburg has held multiple leadership positions in the field of Vascular Medicine including as the Chair of the Peripheral Vascular Disease Council of the American Heart Association, and as a member of the Board of the Society of Vascular Medicine, the American Society of Echocardiography and the Vascular Testing Division of the Intersocietal Accreditation Commission. She co-Chaired the Advanced Training Statement for Vascular Medicine from the American College of Cardiology and the Society of Vascular Medicine. Dr. Hamburg has authored more than 150 scientific papers in the peer reviewed literature and has served on guideline writing committees. She is a past Associate Editor of the journal Vascular Medicine, and current Associate Editor for Circulation Research. She is passionate about improving the care of vascular diseases and reducing the burden of PAD through education. When not working, she enjoys spending time in the mountains hiking and skiing with her husband and two teenage sons.

Publications

  • Published 8/25/2025

    Okazaki RA, Rizvi SH, Bretón-Romero R, Zhou Y, Weisbrod RM, Li Z, Farb MG, Farber A, Hamburg NM. Novel microRNA pathways of impaired angiogenesis in human peripheral artery disease adipose tissue. Vasc Med. 2025 Aug 25; 1358863X251359542. PMID: 40855713.

    Read at: PubMed

  • Published 8/12/2025

    Minetti ET, Erythropel HC, Keith R, Davis DR, Zimmerman JB, Krishnan-Sarin S, Hamburg NM. Cardiovascular Health Effects and Synthetic Cooling Agents in E-Cigarettes Labeled as "Clear" Marketed in Massachusetts After the Tobacco Product Flavoring Ban. J Am Heart Assoc. 2025 Aug 19; 14(16):e036106. PMID: 40792641.

    Read at: PubMed

  • Published 7/21/2025

    Vemulapalli S, Doros G, Weissler EH, Jones WS, Li S, Obrien SM, Beckman JA, Hamburg NM, Jaff MR, Strong MB, Rosenfield K, Menard MT, Farber A, Patel MR. Prediction of 1-Year Major Adverse Cardiovascular Events in Chronic Limb Threatening Ischemia. JACC Adv. 2025 Aug; 4(8):101959. PMID: 40695135.

    Read at: PubMed

  • Published 7/17/2025

    Eberhardt RT, Abola MT, Fukaya E, Ghose T, Gupta K, Hamburg N, Rogers RK, Wells BJ. Funding for vascular medicine fellowships: Learning from the past and planning for the future. Vasc Med. 2025 Aug; 30(4):530-533. PMID: 40671463.

    Read at: PubMed

  • Published 7/2/2025

    Garrett A, Kim B, Gurel NZ, Sie EJ, Wilson BK, Marsili F, Forman JP, Hamburg NM, Boas DA, Roblyer D. Speckle contrast optical spectroscopy for cuffless blood pressure estimation based on microvascular blood flow and volume oscillations. Biomed Opt Express. 2025 Aug 01; 16(8):3004-3016. PMID: 40809974.

    Read at: PubMed

View All 244 Publications:   View Full Profile in BUMC

Other Positions

  • Section Chief, Medicine
    Boston University Chobanian & Avedisian School of Medicine
  • Investigator
    Framingham Heart Study
  • Interim Director, Whitaker Cardiovascular Institute
    Boston University
  • Member, Evans Center for Interdisciplinary Biomedical Research
    Boston University

Websites

Education

  • Harvard Medical School, MD
  • Harvard University, AB

View all profiles